1. Home
  2. SOPH

SOPH

SOPHiA GENETICS SA

Logo SOPHiA GENETICS SA

Health Care

Biotechnology: Biological Products (No Diagnostic Substances)

Nasdaq

as 04-22-2024 4:00pm EST

$
-
.
-
-
+$
-
.
-
-
+
-
.
-
-
%

Sophia Genetics SA is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It has built a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The Company had a physical presence in three countries outside of its headquarters in Switzerland: France, the United States, and Brazil.

Founded: 2011 Country:
Switzerland
Switzerland
Employees: N/A City: N/A
Market Cap: 323.9M IPO Year: 2021
Target Price: $7.75 AVG Volume (30 days): 57.0K
Analyst Decision: Buy Number of Analysts: 4
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -1.22 EPS Growth: N/A
52 Week Low/High: $2.13 - $7.37 Next Earning Date: 05-07-2024
Revenue: $62,371,000 Revenue Growth: 31.14%
Revenue Growth (this year): 30.44% Revenue Growth (next year): 26.82%

Share on Social Networks: